Innate Pharma (IPHA) Times Interest Earned (2019 - 2025)
Historic Times Interest Earned for Innate Pharma (IPHA) over the last 7 years, with Q2 2025 value amounting to $9.07.
- Innate Pharma's Times Interest Earned fell 2884.4% to $9.07 in Q2 2025 from the same period last year, while for Jun 2025 it was $10.17, marking a year-over-year decrease of 4438.22%. This contributed to the annual value of -$12.97 for FY2024, which is 8792.99% down from last year.
- Innate Pharma's Times Interest Earned amounted to $9.07 in Q2 2025, which was down 2884.4% from $12.45 recorded in Q4 2024.
- In the past 5 years, Innate Pharma's Times Interest Earned ranged from a high of $10894.9 in Q4 2022 and a low of $0.41 during Q2 2023
- For the 5-year period, Innate Pharma's Times Interest Earned averaged around $1563.6, with its median value being $11.38 (2021).
- Per our database at Business Quant, Innate Pharma's Times Interest Earned skyrocketed by 9565419.63% in 2022 and then plummeted by 9996.21% in 2023.
- Innate Pharma's Times Interest Earned (Quarter) stood at $11.38 in 2021, then surged by 95654.2% to $10894.9 in 2022, then crashed by 99.96% to $4.13 in 2023, then surged by 201.69% to $12.45 in 2024, then decreased by 27.11% to $9.07 in 2025.
- Its last three reported values are $9.07 in Q2 2025, $12.45 for Q4 2024, and $12.75 during Q2 2024.